Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study.

Patients with positive PD-L1 expression tended to exhibit higher ORR than those with negative expression (22.2% versus 15.6%), but the difference did not reach statistical significance ( p = 0.637).

also in 111,027 other papers